Novozymes and Chr. Hansen announce “perfect match” merger
In Denmark, Novozymes and Chr. Hansen have agreed to merge in a deal that would create a bioscience giant with over €3.5 billion ($3.7 billion) in annual sales and meet growing demand for scalable and sustainable biosolutions. Novozymes is the world’s largest provider of enzyme and microbial technologies, and Chr. Hansen boasts over 145 years’ […]